Join to view full profile
1365 Clifton RdAtlanta, GA 30322
Phone+1 404-441-3167
Dr. Hannan is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Emory University School of MedicineResidency, Gastroenterology, 2016 - 2022- Emory University School of MedicineResidency, Internal Medicine, 2013 - 2016
Georgetown University School of MedicineClass of 2013
Certifications & Licensure
GA State Medical License 2023 - 2028
WA State Medical License 2016 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- A changing landscape in gastric cancer.Lindsay M Hannan, Vaia Florou
CA. 2026-10-01 - Analysis of real-world clinical outcomes of perioperative chemotherapy compared to preoperative chemoradiotherapy in esophagogastric adenocarcinoma.Mosunmoluwa Oyenuga, Subir Goyal, Lindsay M Hannan, Oluwadunni Emiloju, Gideon T Dosunmu
Cancer. 2026-08-15 - 2 citationsTop advances of the year: Reappraisal of systemic versus local therapy for hepatocellular carcinoma.Mosunmoluwa Oyenuga, Tia McGrew, Lindsay M Hannan, Olatunji B Alese
Cancer. 2025-11-01
Lectures
- Clinical predictors of progression of a hepatic lesion from Li-RADS (LR) 3 to LR5 among patients (pts) at risk of hepatocellular carcinoma (HCC).ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/24/2020
- Clinical predictors of radiographic progression of a hepatic lesion from Li-RADS 3 to Li-RADS 5 among a population of individuals at high risk of hepatocellular carcin...2019 ASCO Annual Meeting - 6/1/2019
- A retrospective analysis of clinical outcomes among patients with infiltrative hepatocellular carcinoma (iHCC): A single institution study.2019 ASCO Annual Meeting - 6/1/2019
Press Mentions
Importance of Including Cancer Risk in Discussions About UC TherapyJuly 17th, 2025- Recent Highlights in IBD: Gut-Brain Interaction, Pain Management & Cancer RatesMay 29th, 2025
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: